The VSMC can undergo a proliferative response that underlies the development of in-stent restenosis, bypass graft occlusion and transplant vasculopathy. Although the benefit/risk of therapeutic ...
Since 1999, both stent use and left internal mammary-artery ... including those about off-pump techniques, robotic coronary bypass, and the value of clinical guidelines and pathways for guiding ...
Stent thrombosis is a rare but potentially life threatening complication of percutaneous coronary intervention (PCI). It develops when a blood clot blocks blood flow through your stent. A coronary ...
This is called a drug-eluting balloon. Your physician then collapses the balloon and withdraws the catheter. Your physician may then perform stenting and/or atherectomy. The procedure will take place ...
Balloon angioplasty with drug‐coated balloons (DCBs) is frequently used during percutaneous coronary intervention for in‐stent restenosis. Despite its frequent use, there is a lack of long‐term data ...
while performing angioplasty and stenting procedures in coronary saphenous vein bypass grafts and carotid arteries; the diameter of the vessel at the site of filter loop placement should be between ...
Detour features the EndoCross device and Torus stent grafts. It enables physicians to bypass lesions in the superficial femoral artery by using stents routed through the femoral vein. This ...